Announcement made following a related announcement

Further to the announcement made by Spire Healthcare on 18 February 2026 regarding the discussions between Triton and the Company in the context of the strategic review announced by Spire Healthcare on 18 September 2025, Triton confirms that it does not intend to make a firm offer for Spire Healthcare.

This is a statement to which Rule 2.8 of the Code applies. Accordingly, Triton and any person(s) acting in concert with it will, except with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel"), be bound by the restrictions set out in Rule 2.8 of the Code.

Under Note 2 on Rule 2.8 of the Code, Triton, and any person(s) acting in concert with it, reserve the right to set the restrictions in Rule 2.8 aside in the following circumstances:

• with the agreement of the board of directors of Spire Healthcare;
• following the announcement of a firm intention to make an offer for Spire Healthcare by, or on behalf of, a third party, including Bridgepoint Advisers Limited;
• following the announcement by Spire Healthcare of a Rule 9 waiver proposal (see Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or
• if there has been a material change of circumstances (as determined by the Takeover Panel).